DOSSIER · 13F-HR · Q2 2026

22NW, LP

$105M in tracked AUM across 14 positions as of Q2 2026.

2L
CIK 0001694297 · last filed Jun 30, 2026
Total AUM
$105M
as of Q2 2026
Holdings
14
positions
Whale Score
71
71
strong
Activity
no data
changes this Q
AI Analysis · Q2 2026
Portfolio Overview

The filing for 22NW, LP reveals a period of substantial consolidation and capital reduction during the quarter ending September 30, 2025. The total portfolio value contracted dramatically by 64.8%, falling from approximately $158.81M to $55.86M. This reduction was driven not merely by market performance but by significant asset reallocation, evidenced by the exit from 14 positions. The fund currently maintains a highly concentrated portfolio of only **9 holding...

Key Holdings

The portfolio is characterized by heavy exposure to small-cap and micro-cap companies, with the top three positions accounting for nearly 58.5% of the total assets.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
NSP
INSPERITY INC
$20M493K19.5%
02
NKTR
NEKTAR THERAPEUTICS
$20M281K18.7%
03
SRI
STONERIDGE INC
$18M2.5M17.3%
04
FOXF
FOX FACTORY HLDG CORP
$11M678K11.0%
05
CMT
CORE MOLDING TECHNOLOGIES IN
$6M274K6.2%
06
RGNX
REGENXBIO INC
$6M493K5.6%
07
CULP
CULP INC
$6M1.9M5.5%
08
RZLT
REZOLUTE INC
$4M821K4.1%
09
UFI
UNIFI INC
$4M852K3.9%
10
MLYS
MINERALYS THERAPEUTICS INC
$3M114K2.9%

Filing history

2026Q2Jun 30
$105M 28.3%
14 positionsView →
2026Q1Mar 31
$146M 38.6%
16 positionsView →
2025Q4Dec 31
$238M 325.4%
20 positionsView →
2025Q3Sep 30
$56M 64.8%
9 positionsView →
2025Q2Jun 30
$159M 6.5%
21 positionsLocked
2025Q1Mar 31
$149M 6.0%
20 positionsLocked
2024Q4Dec 31
$159M 32.9%
16 positionsLocked
2024Q3Sep 30
$119M 1.8%
13 positionsLocked
2024Q2Jun 30
$117M 1.0%
13 positionsLocked
2024Q1Mar 31
$116M 24.4%
13 positionsLocked
2023Q4Dec 31
$154M 9.4%
14 positionsLocked
2023Q3Sep 30
$140M 12.4%
14 positionsLocked
Showing 12 of 37